Immunology and Biotherapies
12.9K views | +5 today
Follow
 
Scooped by Gilbert C FAURE
onto Immunology and Biotherapies
Scoop.it!

TiGenix: reaches major cell therapy milestone with 1000th implant of ChondroCelect

TiGenix: reaches major cell therapy milestone with 1000th implant of ChondroCelect | Immunology and Biotherapies | Scoop.it
From BioPortfolio: REGULATED INFORMATIONFEBRUARY 4, 2014 TiGenix reaches major cell therapy milestone with 1000th implant of ChondroCelect Leuven (BELGIUM) - February 4, 2014 - Ti...
more...
No comment yet.
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
Scoop.it!

Resources for DIU Immunologie et Biothérapies

DIU Immunologie et Biotherapies is a french diploma associating many french universities and immunology laboratories. It is dedicated to the involvement of immunology in new biotherapies, either molecular or cellular

Gilbert C FAURE's insight:

We choose Scoop.it as the best curation tool to collect, select, comment informations flowing on the web in this rapidly evolving theme to keep teachers abreast of scientific knowledge and help students surf the wave...

Feel free to be a follower!

 

If you are interested

in Immunology also use http://www.scoop.it/t/immunology

in Mucosal Immunity http://www.scoop.it/t/mucosal-immunity

in Flow Cytometry and Cytomics http://www.scoop.it/t/from-flow-cytometry-to-cytomics

in Allergy an Clinical Immunology http://www.scoop.it/t/allergy-and-clinical-immunology

in Autoimmunity http://www.scoop.it/t/autoimmunity

 

For further informantions on Immune monitoring of Immune therapies, go to

http://www.scoop.it/t/immune-monitoring-1

by MdC

 

Looking for cancer applications inside this topic, use

http://www.scoop.it/t/immunology-and-biotherapies?q=cancer

 

Looking for cytokines and chemokines, use

http://www.scoop.it/t/cytokines-et-chimiokines

 

more...
No comment yet.
Suggested by Société Francaise d'Immunologie
Scoop.it!

Chinese scientists to pioneer first human CRISPR trial

Chinese scientists to pioneer first human CRISPR trial | Immunology and Biotherapies | Scoop.it
Gene-editing technique to treat lung cancer is due to be tested in people in August.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

First gene-editing trial to start next month in China

First gene-editing trial to start next month in China | Immunology and Biotherapies | Scoop.it
The immune cells of lung cancer patients at a hospital in Chengdu, China, are to be modified using the powerful CRISPR-Cas9 gene editing technology so they can target the tumour.
more...
No comment yet.
Rescooped by Gilbert C FAURE from Top Selling Monoclonal Antibodies 2014
Scoop.it!

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis | Immunology and Biotherapies | Scoop.it
Atherosclerotic lesions in mice and humans switch on a ‘don’t eat me’ signal—expression of CD47—that prevents effective removal of diseased tissue; anti-CD47 antibody therapy can normalize this defective efferocytosis, with beneficial results in several mouse models of atherosclerosis.

Via Krishan Maggon
more...
Krishan Maggon 's curator insight, July 21, 2:16 AM
Yoko Kojima, Jens-Peter Volkmer, Kelly McKenna, Mete Civelek, Aldons Jake Lusis, Clint L. Miller, Daniel Direnzo, Vivek Nanda, Jianqin Ye, Andrew J. Connolly, Eric E. Schadt, Thomas Quertermous, Paola Betancur, Lars Maegdefessel, Ljubica Perisic Matic, Ulf Hedin, Irving L. Weissman & Nicholas J. Leeper

Nature (2016) doi:10.1038/nature18935
Published online 20 July 2016
Scooped by Gilbert C FAURE
Scoop.it!

Penn researchers develop plant-based oral vaccine booster

Penn researchers develop plant-based oral vaccine booster | Immunology and Biotherapies | Scoop.it
Jonas Salk created a vaccine against polio that has been used since 1955; Albert Sabin created another version that has been on the market since 1961. Together, these two vaccines have nearly eliminated polio from the face of the earth.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function | Immunology and Biotherapies | Scoop.it
Purpose: The effectiveness of NK cell infusions to induce leukemic remission is limited by lack of both antigen specificity and in vivo expansion.
more...
No comment yet.
Rescooped by Gilbert C FAURE from Top Selling Monoclonal Antibodies 2014
Scoop.it!

Novel human antibody therapeutics: The age of the Umabs

Novel human antibody therapeutics: The age of the Umabs | Immunology and Biotherapies | Scoop.it
Abstract Monoclonal antibodies represent a major and increasingly important category of biotechnology products for the treatment of human diseases. The state-of-the-art of antibody technology has evolved to the point where therapeutic monoclonal antibodies, that are practically indistinguishable from antibodies induced in humans, are routinely generated. We depict how our science-based approach can be used to further improve the efficacy of antibody therapeutics, illustrated by the development of three monoclonal antibodies for various cancer indications: zanolimumab (directed against CD4), ofatumumab (directed against CD20) and zalutumumab (directed against epidermal growth factor receptor).

Via Krishan Maggon
more...
Krishan Maggon 's curator insight, July 16, 12:50 PM
Biotechnol J. 2008 Oct; 3(9-10): 1157–1171. doi: 10.1002/biot.200800110 PMCID: PMC2959493 Novel human antibody therapeutics: The age of the Umabs Sigrid R Ruuls,1 Jeroen J Lammerts van Bueren,1 Jan G J van de Winkel,1,2 and Paul W H I Parren1
Scooped by Gilbert C FAURE
Scoop.it!

Advancing Cancer Therapy Using a Novel Microfluidic device

Advancing Cancer Therapy Using a Novel Microfluidic device | Immunology and Biotherapies | Scoop.it
At SMART (Singapore-MIT Alliance for Research and Technology), husband and wife duo, Dr. Andrea Pavesi and Dr.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Distinct Responses of Stem Cells to Telomere Uncapping—A Potential Strategy to Improve the Safety of Cell Therapy - Liu - 2016 - STEM CELLS - Wiley Online Library

Distinct Responses of Stem Cells to Telomere Uncapping—A Potential Strategy to Improve the Safety of Cell Therapy - Liu - 2016 - STEM CELLS - Wiley Online Library | Immunology and Biotherapies | Scoop.it
In most human somatic cells, the lack of telomerase activity results in progressive telomere shortening during each cell division.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

UPDATED: J&J bags CD28 antagonist from OSE in €155M autoimmune deal | FierceBiotech

UPDATED: J&J bags CD28 antagonist from OSE in €155M autoimmune deal | FierceBiotech | Immunology and Biotherapies | Scoop.it
Johnson & Johnson has exercised its option to license FR104 from OSE Immunotherapeutics.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

French Startup raised €4M for Gene Therapy to fix specific Types of Blindness

French Startup raised €4M for Gene Therapy to fix specific Types of Blindness | Immunology and Biotherapies | Scoop.it
The European Biotech News Website
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Combinatorial antibody libraries: new advances, new immunological insights : Nature Reviews Immunology : Nature Publishing Group

Combinatorial antibody libraries: new advances, new immunological insights : Nature Reviews Immunology : Nature Publishing Group | Immunology and Biotherapies | Scoop.it
more...
No comment yet.
Scooped by Marcelo de Carvalho Bittencourt
Scoop.it!

New Therapy Treats Autoimmune Disease Without Harming Normal Immunity

New Therapy Treats Autoimmune Disease Without Harming Normal Immunity | Immunology and Biotherapies | Scoop.it
In a study with potentially major implications for the future treatment of autoimmunity and related conditions, scientists from the Perelman School of Medicine at the University of Pennsylvania have found a way to remove the subset of antibody-making cells that cause an autoimmune disease, without harming the rest of the immune system.
more...
No comment yet.
Rescooped by Gilbert C FAURE from Top Selling Monoclonal Antibodies 2014
Scoop.it!

Welcome to IMMUTRAIN

Welcome to IMMUTRAIN | Immunology and Biotherapies | Scoop.it
Apply now: 2 PhD Positions in the field of Cancer Immunotherapy @LMU_Uniklinikum - deadline: Aug. 5. https://t.co/QDsjHbPZUV
Via Krishan Maggon
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Chinese Scientists to Pioneer First Human CRISPR Trial

Chinese Scientists to Pioneer First Human CRISPR Trial | Immunology and Biotherapies | Scoop.it
Gene-editing technique to treat lung cancer is due to be tested in people in August
more...
No comment yet.
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review
Scoop.it!

CAR Technology Services

CAR Technology Services | Immunology and Biotherapies | Scoop.it
Recently emerging Chimeric Antigen Receptor (“CAR”) T cell therapy has shown great promise for cancer treatment.
Via Krishan Maggon
more...
No comment yet.
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review
Scoop.it!

Prospecting TCRs for immunotherapy

Prospecting TCRs for immunotherapy | Immunology and Biotherapies | Scoop.it
The elimination of tumors through vaccination or the adoptive transfer of tumor-specific T cells is an attractive option but is technically challenging because of difficulties in raising robust and appropriate immune responses. In Science, Schumacher and colleagues study patients with melanoma and find that their endogenous anti-tumor responses are poor,…

Via Krishan Maggon
more...
Krishan Maggon 's curator insight, July 21, 3:15 AM
Zoltan Fehervari 
Nature Immunology 17, 905 (2016) doi:10.1038/ni.3529 Published online 19 July 2016
Scooped by Gilbert C FAURE
Scoop.it!

HIV Cure Update: Genetically Engineered Proteins Could Remove 85 Percent of HIV-Infected Cells in Laboratory Setting

HIV Cure Update: Genetically Engineered Proteins Could Remove 85 Percent of HIV-Infected Cells in Laboratory Setting | Immunology and Biotherapies | Scoop.it
A new study confirmed the pptency of the new ImmTAV in combination with successful antiretroviral therapy and donated CD8+ T-cells in removing up to 85 percent of HIV-infected cells.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy

Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy | Immunology and Biotherapies | Scoop.it
B7-H3 (CD276) is an important immune checkpoint member of the B7 and CD28 families. Induced on antigen-presenting cells, B7-H3 plays an important role in the inhibition of T-cell function.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

A new drug that could save the US billions just got one step closer to an approval

A new drug that could save the US billions just got one step closer to an approval | Immunology and Biotherapies | Scoop.it
An approved biosimilar of the blockbuster drug Humira could change the way biosimilars are used.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Clinically relevant interpretation of solid phase assays for... : Current Opinion in Organ Transplantation

Clinically relevant interpretation of solid phase assays for... : Current Opinion in Organ Transplantation | Immunology and Biotherapies | Scoop.it
Purpose of review: Accurate and timely detection and characterization of human leukocyte antigen (HL
more...
No comment yet.
Suggested by Société Francaise d'Immunologie
Scoop.it!

New antibody therapy dramatically improves psoriasis symptoms in clinical trial

New antibody therapy dramatically improves psoriasis symptoms in clinical trial | Immunology and Biotherapies | Scoop.it
Only a single treatment produced what researchers describe as 'rapid, substantial, and durable clinical improvement' A sample from one psoriasis patient shows thickening of the outer layer of skin, known as the epidermis (top).
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

What One should know about Medical Tourism?

What One should know about Medical Tourism? | Immunology and Biotherapies | Scoop.it
Medical tourism can be defined as travel from one country to another for the purpose of getting medical treatment there. This has captured the attention of media and researchers in recent times
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Merck: Vaccine manufacturers must innovate or get left behind

Merck: Vaccine manufacturers must innovate or get left behind | Immunology and Biotherapies | Scoop.it
As it enters a collaboration to develop environmentally sustainable yet low-cost vaccines, MilliporeSigma says pharma and regulators must look to next-generation technologies for future vaccine development.
more...
No comment yet.
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review
Scoop.it!

The Immunotherapy Bubble Is Here

The Immunotherapy Bubble Is Here | Immunology and Biotherapies | Scoop.it
There are almost 1,000 clinical trials underway for Immunotherapy against cancer.These drugs will get a fast track approval from the patent office.Merck and Bri
Via Krishan Maggon
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Towards Predicting Protective Vaccine Responses in the Very Young: Trends in Immunology

Kollmann&Marchant on what we know about infant vaccine responses, in #TrendsInImmunology https://t.co/cFxeh9IfaS https://t.co/XoA491U2lB
more...
No comment yet.